Raising a child with a rare disease can feel overwhelming and isolating, but many parents end up being extremely proud of their children’s achievements.

Bertrand Bodson explains the Novartis strategy for digital innovation in asthma care.

Patients with glaucoma, which affects 60 million people worldwide, can lose up to 40 percent of their sight before they begin to notice any change in vision.

Novartis drug hunters leverage machine learning and automation to power a faster, smarter way to navigate to new drugs.